Litigation Details for Supernus Pharmaceuticals, Inc. v. Lee (E.D. Va. 2016)
✉ Email this page to a colleague
Supernus Pharmaceuticals, Inc. v. Lee (E.D. Va. 2016)
| Docket | ⤷ Try a Trial | Date Filed | 2016-03-28 |
| Court | District Court, E.D. Virginia | Date Terminated | 2019-04-10 |
| Cause | 35:154 AIA Appeal of Patent Term Adjustment Determination | Assigned To | Rossie David Alston Jr. |
| Jury Demand | None | Referred To | Ivan D. Davis |
| Patents | 8,747,897 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Supernus Pharmaceuticals, Inc. v. Lee
The small molecule drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for Supernus Pharmaceuticals, Inc. v. Lee (E.D. Va. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-10-18 | 26 | Order on Motion for Summary Judgment | Therapeutic Corporation’s patent, U.S. Patent No. 8,747,897 (“the ‘897 patent”). The issue before the Court…owner and assignee of United States Patent No. 8,747,897 (“the ‘897 patent”), titled “OSMOTIC DRUG DELIVERY…‘897 patent, reflecting a patent term adjustment (“PTA”) of 1,260 days on the face of the patent, Id. …of the United States Patent and Trademark Office’s (“PTO”) determination of patent term adjustment (“PTA…2011, the European Patent Office (“EPO”) published its decision to grant European patent number EP2010189 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
